Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study

Background: The independent association between hepatic steatosis and rheumatoid arthritis is poorly defined. Methods: The presence of moderate to severe steatosis was assessed, using liver ultrasonography, in 364 consecutive non-diabetic subjects (223 patients with rheumatoid arthritis and 141 age-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gian Luca Erre, Floriana Castagna, Assunta Sauchella, Pierluigi Meloni, Arduino Aleksander Mangoni, Giuseppina Farina, Richard Woodman, Maria Pina Dore, Gianpaolo Vidili
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/e32e54fd417c4956a31ed1a7eafbae2c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e32e54fd417c4956a31ed1a7eafbae2c
record_format dspace
spelling oai:doaj.org-article:e32e54fd417c4956a31ed1a7eafbae2c2021-11-19T23:03:46ZPrevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study1759-721810.1177/1759720X211042739https://doaj.org/article/e32e54fd417c4956a31ed1a7eafbae2c2021-11-01T00:00:00Zhttps://doi.org/10.1177/1759720X211042739https://doaj.org/toc/1759-7218Background: The independent association between hepatic steatosis and rheumatoid arthritis is poorly defined. Methods: The presence of moderate to severe steatosis was assessed, using liver ultrasonography, in 364 consecutive non-diabetic subjects (223 patients with rheumatoid arthritis and 141 age- and sex-matched healthy controls). Adjusted multiple regression analysis was performed to explore the association between rheumatoid arthritis and moderate to severe steatosis in the overall sample and identify independent risk factors in the rheumatoid arthritis subgroup. Results: The prevalence of moderate to severe steatosis in the overall sample was 31.3%, with a significantly higher prevalence in patients with rheumatoid arthritis than healthy controls (38.7% versus 19.7%, p  < 0.0001). After adjustment for sex, age, cholesterol, triglycerides, body mass index, waist, hypertension and smoke, rheumatoid arthritis remained significantly associated with moderate to severe steatosis [odds ratio (95% confidence interval) = 2.24 (1.31, 3.84); p  = 0.003]. In the rheumatoid arthritis group, male sex, higher body mass index, higher triglycerides concentrations and higher cumulative dosage of methotrexate [odds ratio (95% confidence interval) = 1.11 (1.01, 1.23); p  = 0.026] were significantly associated with moderate to severe steatosis, while systemic inflammation, disease activity, use of steroids and biologics were not. Conclusion: Rheumatoid arthritis is independently associated with moderate to severe steatosis, with male sex, higher body mass index and cumulative dose of methotrexate being predisposing factors. Further prospective studies are warranted to confirm our findings and to investigate the effect of steatosis on liver outcomes in the rheumatoid arthritis population.Gian Luca ErreFloriana CastagnaAssunta SauchellaPierluigi MeloniArduino Aleksander MangoniGiuseppina FarinaRichard WoodmanMaria Pina DoreGianpaolo VidiliSAGE PublishingarticleDiseases of the musculoskeletal systemRC925-935ENTherapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the musculoskeletal system
RC925-935
spellingShingle Diseases of the musculoskeletal system
RC925-935
Gian Luca Erre
Floriana Castagna
Assunta Sauchella
Pierluigi Meloni
Arduino Aleksander Mangoni
Giuseppina Farina
Richard Woodman
Maria Pina Dore
Gianpaolo Vidili
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
description Background: The independent association between hepatic steatosis and rheumatoid arthritis is poorly defined. Methods: The presence of moderate to severe steatosis was assessed, using liver ultrasonography, in 364 consecutive non-diabetic subjects (223 patients with rheumatoid arthritis and 141 age- and sex-matched healthy controls). Adjusted multiple regression analysis was performed to explore the association between rheumatoid arthritis and moderate to severe steatosis in the overall sample and identify independent risk factors in the rheumatoid arthritis subgroup. Results: The prevalence of moderate to severe steatosis in the overall sample was 31.3%, with a significantly higher prevalence in patients with rheumatoid arthritis than healthy controls (38.7% versus 19.7%, p  < 0.0001). After adjustment for sex, age, cholesterol, triglycerides, body mass index, waist, hypertension and smoke, rheumatoid arthritis remained significantly associated with moderate to severe steatosis [odds ratio (95% confidence interval) = 2.24 (1.31, 3.84); p  = 0.003]. In the rheumatoid arthritis group, male sex, higher body mass index, higher triglycerides concentrations and higher cumulative dosage of methotrexate [odds ratio (95% confidence interval) = 1.11 (1.01, 1.23); p  = 0.026] were significantly associated with moderate to severe steatosis, while systemic inflammation, disease activity, use of steroids and biologics were not. Conclusion: Rheumatoid arthritis is independently associated with moderate to severe steatosis, with male sex, higher body mass index and cumulative dose of methotrexate being predisposing factors. Further prospective studies are warranted to confirm our findings and to investigate the effect of steatosis on liver outcomes in the rheumatoid arthritis population.
format article
author Gian Luca Erre
Floriana Castagna
Assunta Sauchella
Pierluigi Meloni
Arduino Aleksander Mangoni
Giuseppina Farina
Richard Woodman
Maria Pina Dore
Gianpaolo Vidili
author_facet Gian Luca Erre
Floriana Castagna
Assunta Sauchella
Pierluigi Meloni
Arduino Aleksander Mangoni
Giuseppina Farina
Richard Woodman
Maria Pina Dore
Gianpaolo Vidili
author_sort Gian Luca Erre
title Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
title_short Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
title_full Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
title_fullStr Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
title_full_unstemmed Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
title_sort prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/e32e54fd417c4956a31ed1a7eafbae2c
work_keys_str_mv AT gianlucaerre prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT florianacastagna prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT assuntasauchella prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT pierluigimeloni prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT arduinoaleksandermangoni prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT giuseppinafarina prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT richardwoodman prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT mariapinadore prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
AT gianpaolovidili prevalenceandriskfactorsofmoderatetoseverehepaticsteatosisinpatientswithrheumatoidarthritisanultrasonographycrosssectionalcasecontrolstudy
_version_ 1718419869472391168